ABCL – AbCellera Biologics Inc.
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ABCL
#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ABCL
&conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]
Float Short %
23.61
Margin Of Safety %
Put/Call OI Ratio
0.16
EPS Next Q Diff
EPS Last/This Y
-0.1
EPS This/Next Y
-0.04
Price
3.59
Target Price
9.83
Analyst Recom
1.25
Performance Q
-15.33
Relative Volume
0.49
Beta
0.73
Ticker: ABCL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-11-10 | ABCL | 4.03 | 0.19 | 0.01 | 107009 |
| 2025-11-11 | ABCL | 4 | 0.17 | 0.10 | 119268 |
| 2025-11-12 | ABCL | 3.95 | 0.17 | 3.29 | 118915 |
| 2025-11-13 | ABCL | 3.61 | 0.17 | 0.16 | 118541 |
| 2025-11-14 | ABCL | 3.7 | 0.17 | 0.35 | 117803 |
| 2025-11-17 | ABCL | 3.59 | 0.17 | 0.08 | 118298 |
| 2025-11-18 | ABCL | 3.67 | 0.17 | 0.35 | 118634 |
| 2025-11-19 | ABCL | 3.62 | 0.14 | 0.35 | 117631 |
| 2025-11-20 | ABCL | 3.39 | 0.14 | 0.12 | 117215 |
| 2025-11-21 | ABCL | 3.51 | 0.13 | 0.12 | 116321 |
| 2025-11-24 | ABCL | 3.58 | 0.12 | 0.12 | 101823 |
| 2025-11-25 | ABCL | 3.63 | 0.12 | 0.19 | 102652 |
| 2025-11-26 | ABCL | 3.63 | 0.12 | 1.80 | 102917 |
| 2025-12-01 | ABCL | 3.45 | 0.16 | 0.08 | 106981 |
| 2025-12-02 | ABCL | 3.47 | 0.16 | 0.11 | 106901 |
| 2025-12-03 | ABCL | 3.49 | 0.16 | 0.01 | 108014 |
| 2025-12-04 | ABCL | 3.66 | 0.16 | 0.11 | 108284 |
| 2025-12-05 | ABCL | 3.57 | 0.16 | 0.51 | 109400 |
| 2025-12-08 | ABCL | 3.6 | 0.16 | 0.08 | 109997 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-11-10 | ABCL | 4.03 | 4.7 | - | -0.60 |
| 2025-11-11 | ABCL | 4.01 | 4.7 | - | -0.66 |
| 2025-11-12 | ABCL | 3.95 | 4.7 | - | -0.66 |
| 2025-11-13 | ABCL | 3.60 | 4.7 | - | -0.66 |
| 2025-11-14 | ABCL | 3.70 | -83.3 | - | -0.66 |
| 2025-11-17 | ABCL | 3.60 | -43.3 | - | -0.64 |
| 2025-11-18 | ABCL | 3.66 | -43.3 | - | -0.64 |
| 2025-11-19 | ABCL | 3.61 | -43.3 | - | -0.64 |
| 2025-11-20 | ABCL | 3.39 | -43.3 | - | -0.64 |
| 2025-11-21 | ABCL | 3.51 | -45.8 | - | -0.64 |
| 2025-11-24 | ABCL | 3.57 | -45.8 | - | -0.64 |
| 2025-11-25 | ABCL | 3.62 | -45.8 | - | -0.65 |
| 2025-11-26 | ABCL | 3.63 | -45.8 | - | -0.65 |
| 2025-12-01 | ABCL | 3.46 | -58.3 | - | -0.65 |
| 2025-12-02 | ABCL | 3.46 | -58.3 | - | -0.65 |
| 2025-12-03 | ABCL | 3.49 | -58.3 | - | -0.65 |
| 2025-12-04 | ABCL | 3.66 | -58.3 | - | -0.65 |
| 2025-12-05 | ABCL | 3.56 | -58.3 | - | -0.65 |
| 2025-12-08 | ABCL | 3.59 | -58.3 | - | -0.65 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-11-10 | ABCL | 0.00 | -9.33 | 23.56 |
| 2025-11-11 | ABCL | 0.00 | -9.33 | 23.56 |
| 2025-11-12 | ABCL | 0.00 | -9.33 | 24.43 |
| 2025-11-13 | ABCL | 0.00 | -9.33 | 24.34 |
| 2025-11-14 | ABCL | 0.00 | -9.33 | 24.34 |
| 2025-11-17 | ABCL | 0.00 | -1.01 | 24.34 |
| 2025-11-18 | ABCL | 0.00 | -1.01 | 24.34 |
| 2025-11-19 | ABCL | 0.00 | -1.01 | 24.34 |
| 2025-11-20 | ABCL | 0.00 | -1.01 | 24.34 |
| 2025-11-21 | ABCL | 0.00 | -1.01 | 23.91 |
| 2025-11-24 | ABCL | 0.00 | -1.78 | 23.91 |
| 2025-11-25 | ABCL | 0.00 | -1.78 | 23.91 |
| 2025-11-26 | ABCL | 0.00 | -1.78 | 23.60 |
| 2025-12-01 | ABCL | 0.00 | -1.77 | 23.61 |
| 2025-12-02 | ABCL | 0.00 | -1.77 | 23.61 |
| 2025-12-03 | ABCL | 0.00 | -1.77 | 23.61 |
| 2025-12-04 | ABCL | 0.00 | -1.77 | 23.61 |
| 2025-12-05 | ABCL | 0.00 | -1.77 | 23.61 |
| 2025-12-08 | ABCL | 0.00 | -1.78 | 23.61 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ABCL
589 360 ]
Last Quarter Act. EPS
-0.19
Avg. EPS Est. Current Quarter
-0.19
Avg. EPS Est. Next Quarter
-0.18
Insider Transactions
Institutional Transactions
-1.78
Beta
0.73
Average Sales Estimate Current Quarter
6
Average Sales Estimate Next Quarter
14
Fair Value
Quality Score
21
Growth Score
28
Sentiment Score
34
Actual DrawDown %
95
Max Drawdown 5-Year %
Target Price
9.83
P/E
Forward P/E
PEG
P/S
30.42
P/B
1.11
P/Free Cash Flow
EPS
-0.58
Average EPS Est. Cur. Y
-0.65
EPS Next Y. (Est.)
-0.69
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-486.01
Relative Volume
0.49
Return on Equity vs Sector %
-44.7
Return on Equity vs Industry %
-29.8
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.05
EBIT Estimation
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ABCL
589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ABCL
589 450 ]
AbCellera Biologics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 596
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
stock quote shares ABCL – AbCellera Biologics Inc. Stock Price stock today
news today ABCL – AbCellera Biologics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ABCL – AbCellera Biologics Inc. yahoo finance google finance
stock history ABCL – AbCellera Biologics Inc. invest stock market
stock prices ABCL
premarket after hours
ticker ABCL
fair value insiders trading